Reexamination of Patient Autonomy and Prior Therapies in Oncology Clinical Trial Eligibility Criteria Reply

被引：0
|
作者：
Hope, Thomas A. [1 ,2 ,3 ]
Calais, Jeremie [4 ,5 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St,Ste 350, San Francisco, CA 94107 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] San Francisco VA Med Ctr, Dept Radiol & Biomed Imaging, San Francisco, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[5] Univ Duisburg Essen, German Canc Consortium DKTK, Dept Nucl Med, Univ Hosp Essen, Essen, Germany
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reexamination of Patient Autonomy and Prior Therapies in Oncology Clinical Trial Eligibility Criteria
    Gao, Jennifer J.
    Pazdur, Richard
    Beaver, Julia A.
    JAMA ONCOLOGY, 2022, 8 (04) : 513 - 514
  • [2] Oncology trial eligibility criteria
    Williamson, Jack
    LANCET HEALTHY LONGEVITY, 2021, 2 (05): : E249 - E249
  • [3] Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World
    Karim, S.
    Xu, Y.
    Kong, S.
    Abdel-Rahman, O.
    Quan, M. L.
    Cheung, W. Y.
    CLINICAL ONCOLOGY, 2019, 31 (09) : E160 - E166
  • [4] Assessing the interpretation of criteria for clinical trial eligibility: a survey of oncology investigators
    Weijer, C
    Freedman, B
    Shapiro, S
    Fuks, A
    Skrutkowska, M
    Sigurjonsdottir, M
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1998, 21 (01): : 17 - 26
  • [5] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group
    Osarogiagbon, Raymond U.
    Vega, Diana Merino
    Fashoyin-Aje, Lola
    Wedam, Suparna
    Ison, Gwynn
    Atienza, Sol
    De Porre, Peter
    Biswas, Tithi
    Holloway, Jamie N.
    Hong, David S.
    Wempe, Madison M.
    Schilsky, Richard L.
    Kim, Edward S.
    Wade, James L., III
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2408 - 2415
  • [6] Thoracic Oncology Clinical Trial Eligibility Criteria: Ongoing Increase in Recent Years
    Gerber, David E.
    Garcia, Sandra
    Yan, Jingsheng
    Xie, Xian-Jin
    Ramalingam, Suresh
    Schiller, Joan
    Johnson, David
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S270 - S271
  • [7] Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
    Tan, Aaron C.
    Boggs, Drexell H.
    Lee, Eudocia Q.
    Kim, Michelle M.
    Mehta, Minesh P.
    Khasraw, Mustafa
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [8] Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
    Muneer J. Al-Husseini
    Anas M. Saad
    Hadeer H. Mohamed
    Mohamad A. Alkhayat
    Mohamad Bassam Sonbol
    Omar Abdel-Rahman
    BMC Cancer, 19
  • [9] Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity
    Garcia, Sandra
    Bisen, Ajit
    Yan, Jingsheng
    Xie, Xian-Jin
    Ramalingam, Suresh
    Schiller, Joan H.
    Johnson, David H.
    Gerber, David E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (10) : 1489 - 1495
  • [10] Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
    Sun, Xuqi
    Li, Lingling
    Xu, Li
    Zhou, Zhongguo
    Chen, Jinbin
    Wang, Juncheng
    Zhang, Yaojun
    Hu, Dandan
    Chen, Minshan
    BMC CANCER, 2021, 21 (01)
12345